Microsoft, Gigaset, Phyton, McDonald’s: Intellectual Property

By:Victoria Slind-Flor

Oct. 25 (Bloomberg) -- Microsoft Corp. signed a deal with Compal Electronics Inc. for tablets, mobile phones, e-readers and other consumer devices running the Android or Chrome platform.

Specific details and financial terms of the agreement weren’t disclosed other than a mention that the company will receive royalties from Taipei-based Compal, Microsoft said in a statement.

Microsoft’s patent licensing business began when Marshall Phelps joined the Redmond, Washington-based software company in 2003 after spending 28 years growing patent-licensing into a billion dollar business at International Business Machines Corp. Phelps was Microsoft’s Corporate Vice President and Deputy General Counsel for Intellectual Property and Licensing until his departure in 2010.

The company began using litigation as part of its patent- licensing strategy after Horacio Gutierrez took over management of the company’s patent portfolio in 2006.

In the Microsoft statement, Gutierrez said the licensing agreement with Compal meant that more than half the companies in involved in original design manufacturing for Chrome and Android have now taken a license to his company’s patent portfolio.

Gigaset Files Patent Infringement Suit Against AVM in Germany

Gigaset AG’s Gigaset Communications unit filed a lawsuit against FRITZ! Box manufacturer AVM Computer Vertriebs GmbH at a Dusseldorf district court on Oct. 21.

Gigaset, a maker of cordless telephones, said in a statement yesterday that several products in the AVM FRITZ! range infringe a “fundamental” Gigaset patent.

The company is seeking money damages and an injunction regarding the use of its technology. It also asked for a court order for destruction of the allegedly infringing products.

Phyton Sues Samyang in Germany Over Paclitaxel Production Patent

Phyton Ltd.’s Phyton Biotech unit filed a patent- infringement suit against Seoul’s Samyang Corp., according to a company statement.

The suit, filed in a German court, is related to a patent for plant cell fermentation using cell lines derived from the Taxus species to produce the paclitaxel compound. Taxus is the family to which yew trees belong, and paclitaxel is used to treat a variety of cancers.

Phyton claims Samyang’s method of producing paclitaxel infringed the patent. It asked the court to order Samyang to halt its alleged infringement, and requested a ban on the sale and use of Samyang’s paclitaxel in Germany.

Phyton, based in San Antonio, is a global supplier of paclitaxel and docetaxel, a related anti-cancer compound also produced from yew trees.